Skip to content
Fresh Jackpot Plus

Users Coming Off Weight-Loss Jabs Gain Back Weight at a Quadrupled Rate Than Dieters

Illustration of pharmaceutical injection and weighing machine
Weight management involves long-term strategies.

New research indicates that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle programs.

Findings released in a major medical journal shows that while overweight people can lose a large proportion of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Users using such drugs must be cognizant of the risk of quick rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a reversion to starting weight in about one and a half years.

Weighing Treatments

The analysis, which examined dozens of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

The team note that individuals who lose weight through lifestyle changes alone typically experience a more gradual weight regain—perhaps 100 grams monthly—after stopping.

The Reason for the Fast Rebound

Doctors believe the way of the injections explains the heightened regain.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication results in appetite is unsuppressed, making excessive eating far more likely."

A Lifelong Disease?

The NHS recommend the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

A number of clinicians argue that, given the likelihood of weight regain, the therapy should be considered ongoing.

This perspective is supported by pharmaceutical companies, who say that the results "highlight the chronic character of excess weight," comparing it to managing diseases like diabetes.

Patient Accounts

Users who have discontinued the jabs explain a intense resurgence of hunger.

"I experienced something activating and you're instantly starving," described a patient.

This challenge is exacerbated if users have not established lasting dietary or behavioural modifications during therapy.

Growing Use

Survey data indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.

  • Adoption is more common among females compared to males.
  • The 40s and 50s demographic shows the highest level of interest.
  • Many access the drugs through private prescriptions rather than public health services.

Ultimately, clinicians stress that while the jabs are potent tools for weight loss, they are not a permanent solution and lasting health benefits relies on combined lifestyle changes.

The writer

Jose Hughes

A seasoned casino analyst with over a decade of experience in gaming industry trends and player strategy optimization.

Fresh Jackpot Plus

Type to search articles.